BIOCEPT INC Annual Net Cash Provided by (Used in) Financing Activities in USD from 2017 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Biocept Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2017 to 2022.
  • Biocept Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $162K.
  • Biocept Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$1.87M, a 115% decline from 2021.
  • Biocept Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $12.4M, a 51.9% decline from 2020.
  • Biocept Inc annual Net Cash Provided by (Used in) Financing Activities for 2020 was $25.7M, a 13.3% decline from 2019.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$1.87M -$14.2M -115% Jan 1, 2022 Dec 31, 2022 10-K 2023-04-17
2021 $12.4M -$13.3M -51.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-17
2020 $25.7M -$3.94M -13.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-05
2019 $29.7M +$5.89M +24.8% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $23.8M +$5.19M +27.9% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-27
2017 $18.6M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.